Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

PerkinElmer Completes ShanghaiHaoyuan Biotech Acquisition

RELATED NEWS
Trade PKI now with 

PerkinElmer, Inc. (PKI: Quote) Monday said it has completed the acquisition of ShanghaiHaoyuan Biotech Co., Ltd., a China-based infectious disease diagnostics company.

The Haoyuan acquisition enables PerkinElmer to supply advanced, highly sensitive diagnostics screenings to these banks, ensuring that HBV, HCV and HIV are accurately detected prior to transfusion.

Simultaneously, this product integration strengthens the safety of the blood banks in China while creating an opportunity for future implementation in other countries.

Click here to receive FREE breaking news email alerts for PerkinElmer and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Colorado based doctor Dilip Joseph, who was kidnapped by the Taliban discusses his ordeal in detail in a book published by Amazon on Tuesday. Extending the rebound seen over the course of the previous session, stocks moved sharply higher during trading on Friday. The gains on the day partly offset the recent sell-off on Wall Street, although the major averages remain well off their mid-September highs. While the Ebola outbreak in the U.S. has thus far been limited to just three people, the results of a new CBS News poll suggest that news of the disease has contributed to a sharp drop in public confidence in the Centers for Disease Control and Prevention.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.